Home › Bile Duct Cancer (Cholangiocarcinoma) › New York
Pag-aaral pangklinika para sa Bile Duct Cancer (Cholangiocarcinoma) sa New York
15 pag-aaral para sa Bile Duct Cancer (Cholangiocarcinoma) ang naghahanap ng mga kalahok sa mga site sa New York.
Mga Lungsod sa New York
Opisyal na teksto ng pag-aaral (English)
A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement
- Roswell Park Cancer Institute, Buffalo
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06728410A Study of PHST001 in Advanced Solid Tumors
- START Center for Cancer Research - Long Island New York, Lake Success
- Mount Sinai, New York
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06840886A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- START New York Long Island LLC, Lake Success
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06270706A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
- Rosewell Park Comprehensive Cancer Center (Site 114), Buffalo
- Memorial Sloan Kettering Cancer Center (Site 108), New York
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07265674A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- New York University (NYU) Clinical Cancer Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07213791A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- START New York, Lake Success
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07488676Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
- Memorial Sloan Kettering Cancer Centers, New York
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06282575Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- New York University Langone Health, New York
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05732831Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
- Memorial Sloan Kettering Commack - Limited Protocol Activities, Commack
- Memorial Sloan Kettering Westchester - Limited Protocol Activities, Harrison
- Memorial Sloan Kettering Cancer Center, New York
- at 1 pa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT04891289HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer
- Montefiore Medical Center, The Bronx
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT06899152Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
- New York Presbyterian Hospital-Columbia University Medical Center, New York
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT07486713A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Nagre-recruitPhase 2
Edad 8 pataas · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT05503797A Study of MGC028 in Participants With Advanced Solid Tumors
- Icahn School of Medicine at Mt. Sinai, New York
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 27, 2026 · NCT06723236SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Buffalo
- Massive Bio SYNERGY-AI site, Hempstead
- Massive Bio SYNERGY-AI site, Manhasset
- at 2 pa
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774The Dragon PLC Trial (DRAGON-PLC)
- Memorial Sloan Kettering Cancer Center, New York
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update May 15, 2025 · NCT06914648Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.